Chronic inflammation is a common feature of both conditions, with inflammatory cytokines like tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) promoting insulin resistance, a hallmark of T2D. This evidence concerns the gene IL6 and Insulin resistance.